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Background: Surgical-site infection (SSI) is a potentially serious complication following colorectal
surgery. The present systematic review and meta-analysis aimed to investigate the effect of preoperative
oral antibiotics and mechanical bowel preparation (MBP) on SSI rates.
Methods: A systematic review of PubMed, Cochrane Database of Systematic Reviews and Cochrane
Central Register of Controlled Trials was performed using appropriate keywords. Included were RCTs
and observational studies reporting rates of SSI following elective colorectal surgery, in patients given
preoperative oral antibiotic prophylaxis, in combination with intravenous (i.v.) antibiotic prophylaxis
and MBP, compared with patients given only i.v. antibiotic prophylaxis with MBP. A meta-analysis was
undertaken.
Results: Twenty-two studies (57 207 patients) were included, of which 14 were RCTs and eight observa-
tional studies. Preoperative oral antibiotics, in combination with i.v. antibiotics and MBP, were asso-
ciated with significantly lower rates of SSI than combined i.v. antibiotics and MBP in RCTs (odds
ratio (OR) 0⋅45, 95 per cent c.i. 0⋅34 to 0⋅59; P<0⋅001) and cohort studies (OR 0⋅47, 0⋅44 to 0⋅50;
P< 0⋅001). There was a similarly significant effect on SSI with use of a combination of preoperative oral
aminoglycoside and erythromycin (OR 0⋅40, 0⋅25 to 0⋅64; P< 0⋅001), or preoperative oral aminoglycoside
andmetronidazole (OR 0⋅51, 0⋅39 to 0⋅68; P<0⋅001). Preoperative oral antibiotics were significantly asso-
ciated with reduced postoperative rates of anastomotic leak, ileus, reoperation, readmission and mortality
in the cohort studies.
Conclusion: Oral antibiotic prophylaxis, in combination withMBP and i.v. antibiotics, is superior toMBP
and i.v. antibiotic prophylaxis alone in reducing SSI in elective colorectal surgery.
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Introduction
Surgical-site infection (SSI) is a challenging problem fol-
lowing colorectal surgery. SSI can be separated into super-
ficial and deep components, and is reported routinely until
30 days after surgery. SSI represents not only a costly
expense to health services, but more importantly influences
patient recovery and survival1.
Various strategies have been adopted in attempts to
reduce postoperative SSI rates. Mechanical bowel prepara-
tion (MBP) alone has been shown in large data sets to have
no influence on SSI2. The value of i.v. antibiotics in the
immediate preoperative period is clearly established and
they are currently used worldwide, with or without MBP3.
Advocates of preoperative antibiotics believe that cleansing
of intestinal flora influences rates of subsequent infection.
Controversy remains regarding the use of short-course
oral antibiotics in the preoperative setting; although use
of oral antibiotics in combination with MBP is a strat-
egy employed widely in North America4, it remains much
less common across Europe. The reasons for avoidance of
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MBP in Europe are multifactorial, but the trend towards
enhanced recovery after surgery (ERAS) protocols that
exclude routineMBP is probably a significant contributor5.
Concerns regarding hospital-acquired infections includ-
ing Clostridium difficile are relevant only when patients are
exposed to extended bowel-cleansing protocols6. The aim
of this review was to assess only trials that included 1 day
of preoperative antibiotics, and all trials assessing longer
periods of preoperative antibiotic exposure were excluded.
Although the evidence for and against MBP can be
debated, guidelines clearly state that there is no strong
evidence for its use alone7. Evidence exists that suggests
that its use in addition to oral antibiotics as part of a
bowel-cleansing protocol is beneficial with respect to SSI4.
The impact of the use of oral antibiotics in the absence of
MBP with regard to SSI has not been established. Anti-
biotics are thought to have little influence in this context
because of the faecal content present.
The value of employing different regimens of oral anti-
biotics has also not been clearly established. Most
trials have used the combination of an aminoglyco-
side (neomycin or kanamycin) with a macrolide such as
erythromycin or with metronidazole.
The aim of the present study was to examine the impact
of oral antibiotics and MBP given on the day before oper-
ation, in combination with i.v. antibiotic prophylaxis at
induction of anaesthesia, on rates of SSI following elective
colorectal surgery. Secondary outcome measures included
anastomotic leak, reoperation, duration of hospital stay,
readmission and mortality. RCTs and observational studies
that have assessed the role of preoperative oral antibiotics
in the reduction of SSI in colorectal surgery were consid-
ered for inclusion, with the aim of determining the value of
employing this preoperative strategy and to assess the best
antibiotic combination available.
Methods
The systematic review and meta-analysis was performed
and reported in accordance with the PRISMA statement8.
Outcomes of interest
The primary outcome was the impact of preoperative oral
antibiotic prophylaxis given the day before surgery, in
combinationwith i.v. antibiotic prophylaxis andMBP, com-
pared with that in patients given only i.v. antibiotic prophy-
laxis withMBP, on rates of SSI following elective colorectal
surgery. Secondary outcomes included: the impact of pre-
operative antibiotic prophylaxis on organ space SSI, anas-
tomotic leak, postoperative ileus, unplanned return to the
operating theatre, readmission and mortality. Postopera-
tive SSI, anastomotic leak, ileus, return to theatre, read-
mission and mortality were recorded as categorized by the
authors of the included studies.
Literature search and study selection
A systematic literature review was undertaken of PubMed,
the Cochrane Database of Systematic Reviews and the
Cochrane Central Register of Controlled Trials from
inception to March 2017 inclusive. Combinations of the
following search terms were used; [title/abstract]: (colo-
rectal OR colon OR rectal OR colonic OR rectum)
AND (surgery OR operation) AND (antibiotic OR anti-
microbial). Abstracts were screened for relevance. Animal
or preclinical studies, studies not published in English
and review articles were excluded. Included were RCTs
and observational studies reporting rates of SSI following
elective colorectal surgery in patients given preopera-
tive oral antibiotic prophylaxis, in combination with i.v.
antibiotic prophylaxis and MBP, compared with those in
patients given only i.v. antibiotic prophylaxis with MBP.
Studies reporting prolonged preoperative oral antibiotic
regimens, without the use of MBP in both groups, without
i.v. antibiotic prophylaxis in both groups, and including
patients undergoing emergency surgery, were excluded.
Relevant full-text articles were then appraised. Reference
lists of included studies were hand-searched for further
relevant studies. Two authors performed study selection
and data extraction, and any uncertainties were resolved
by consensus discussion with the senior author.
Data extraction and meta-analysis
Data were extracted and analysis performed using Review
Manager version 5.3 (The Nordic Cochrane Centre, The
Cochrane Collaboration, Copenhagen, Denmark). Odds
ratios (ORs) and 95 per cent confidence intervals were cal-
culated from the total number of patients and the number
of events within each group. Meta-analysis of the impact
of preoperative oral antibiotics on SSI, anastomotic leak,
reoperation, readmission and mortality rates was carried
out using the Mantel–Haenzsel method. Meta-analysis of
the impact of preoperative oral antibiotics on postoper-
ative length of hospital stay was done by calculating the
mean difference and 95 per cent confidence interval using
the inverse-variancemethod.Where data other thanmeans
and standard deviations were reported, an attempt was
made to calculate these values using published confidence
intervals or P values, as described in the Cochrane Hand-
book for Systematic Reviews of Interventions9, or by Wan and
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colleagues10. A fixed-effects model was used unless there
was significant evidence of heterogeneity when quanti-
fied using the I2 statistic, in which case a random-effects
model was used. The significance of the overall effect was
determined using the Z test. P≤ 0⋅050 was considered sta-
tistically significant.
Assessment of bias
Assessment of the risk of bias was carried out using the
Cochrane Collaboration tool provided by ReviewManager
version 5.3. Data were assessed for heterogeneity using the
I2 statistic, with guidance from the Cochrane Handbook for
Systematic Reviews of Interventions9. A prespecified sensitiv-
ity analysis was undertaken by estimating the treatment
effect size only in double-blind RCTs, and comparing this
with the overall results. Assessment of potential publication
bias was carried out by visual inspection of funnel plots.
Results
Study selection
The study selection process is summarized in Fig. 1. Some
1036 abstracts were identified. At screening, 517 were
excluded, of which 133 were animal or preclinical stud-
ies, 223 were not in the English language, 161 were review
articles and 476 were not relevant to the review. After
assessment of full-text articles of the remaining 43 stud-
ies, 18 studies were excluded owing to the lack of MBP,
prolonged courses of preoperative oral antibiotics, or the
inclusion of patients undergoing emergency or urgent
surgery. A further three studies were excluded as they were
duplicate publications using cohorts already included in
the meta-analysis11–13. The remaining 22 studies were
included in the review, of which 14 were RCTs14–27, and
eight were observational cohorts2,4,28–33 (Table 1; Table S1,
supporting information). These studies included a total of
57 207 patients.
Validity assessment
The risk of study bias is summarized in Fig. S1 (supporting
information). Of the included RCTs, five14,16,18,20,22 were
double-blinded, three15,17,23 were single-blinded, and the
remainder were unblinded. Most of the included cohort
studies were at low risk of bias.
Rates of all SSIs following colorectal surgery
In the 14 RCTs14–27, involving 3014 patients, rates of SSI
in patients given preoperative oral antibiotic prophylaxis,
Records identified by search strategy
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 Review n=161
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Fig. 1 PRISMA flow chart showing selection of articles for review
in combination with i.v. antibiotic prophylaxis and MBP,
were compared with those in patients who received only
i.v. antibiotic prophylaxis with MBP (Fig. 2). There was
minimal heterogeneity between studies (I2 = 12 per cent,
P= 0⋅33) and therefore a fixed-effect model was used. Pre-
operative oral antibiotics were significantly associated with
lower rates of SSI (OR 0⋅45, 95 per cent c.i. 0⋅34 to 0⋅59;
P< 0⋅001).
Eight cohort studies2,4,28–33, including 54 193 patients,
compared rates of SSI in patients given preoperative oral
antibiotic prophylaxis, in combination with i.v. antibiotic
prophylaxis and MBP, with those in patients given only
i.v. antibiotic prophylaxis with MBP (Fig. 2). There was
moderate heterogeneity between studies (I2 = 48 per cent,
P= 0⋅06) and therefore a fixed-effect model was used. Pre-
operative oral antibiotics were significantly associated with
lower rates of SSI (OR 0⋅47, 0⋅44 to 0⋅50; P< 0⋅001).
Impact of oral antibiotic combination on overall
SSI rates
Seven RCTs14,16–18,20,21,24, involving 1141 patients, exam-
ined rates of SSI in patients given a preoperative oral
combination of an oral aminoglycoside (kanamycin or
neomycin) and erythromycin, along with i.v. antibiotic
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Table 1 Characteristics of included studies
Reference
Type of
study Placebo
Oral antibiotic
combination Intravenous antibiotic MBP SSI criteria
Secondary
outcomes
Barber et al.14 RCT Yes Neomycin +
erythromycin
Clindamycin +
gentamicin
Magnesium citrate Custom –
Hanel et al.15 RCT No 1g neomycin × 6 +
200mg
metronidazole × 16
Clindamycin +
cefazolin
Clear fluids for 4 days Custom –
Kaiser et al.16 RCT Yes 1g neomycin + 1g
erythromycin × 3
2g cefoxitin or 1 g
cefazolin × 1
Magnesium citrate Custom –
Lau et al.17 RCT No 1g neomycin + 1g
erythromycin × 3
500mg metronidazole
+ 2mg/kg
gentamicin × 3
Bisacodyl +
magnesium citrate
Lungqvist criteria Organ space SSI, leak,
LOS
Khubchandani
et al.18
RCT No 1g neomycin + 1g
erythromycin × 3
1g cefazolin + 1g
metronidazole × 3
Castor oil Custom Leak
Reynolds
et al.19
RCT No Neomycin +
metronidazole
n.r. n.r. Custom –
Stellato et al.20 RCT No 1g neomycin +1g
erythromycin × 1
2g cefoxitin ×1 Magnesium
citrate+ sodium
phosphate
Custom –
Ishida et al.21 RCT No 500mg kanamycin +
400mg
erythromycin ×8
1g cefotiam ×6 PEG CDC Organ space SSI, leak
Lewis22 RCT Yes 2g neomycin + 2g
metronidazole × 2
1g amikacin + 1g
metronidazole × 1
Sodium phosphate CDC Organ space SSI, leak
Espin-Basany
et al.23
RCT No 1g neomycin + 1g
metronidazole × 3
1g cefoxitin × 3 Sodium phosphate CDC Organ space SSI, ileus
Kobayashi
et al.24
RCT No 1g kanamycin +
400mg
erythromycin × 3
1g cefmetazole × 1 PEG CDC –
Oshima et al.25 RCT No 500mg kanamycin +
500mg
metronidazole × 3
1g flomoxef Magnesium citrate NNIS Organ space SSI
Sadahiro
et al.26
RCT No 500mg kanamycin +
500mg
metronidazole × 3
1g flomoxef × 1 Sodium bicosulphate
+ PEG
Custom Organ space SSI, leak
Hata et al.27 RCT No 1g kanamycin +
750mg
metronidazole × 2
1g cefmetazole × 1 Sodium picosulphate
+ magnesium citrate
CDC Organ space SSI, leak,
ileus
Konishi et al.28 Cohort n.a. Kanamycin +
metronidazole
Second-generation
cephalosporin
NNIS –
Cannon et al.29 Cohort n.a. n.r. n.r. PEG, sodium
phosphate or
magnesium citrate
VASQIP –
Hendren
et al.30
Cohort n.a. n.r. n.r. n.r. ACS NSQIP –
Morris et al.31 Cohort n.a. n.r. n.r. n.r. Custom Organ space SSI, leak,
ileus, reoperation, LOS,
readmission, mortality
Scarborough
et al.4
Cohort n.a. n.r. n.r. n.r. ACS NSQIP Leak, LOS, readmission,
mortality
Moghadamye-
ghaneh
et al.32
Cohort n.a. n.r. n.r. n.r. ICD-9 Organ space SSI, leak,
reoperation, LOS,
mortality
Kiran et al.33 Cohort n.a. n.r. n.r. n.r. ACS NSQIP Organ space SSI, leak,
ileus, readmission,
reoperation, mortality
Koller et al.2 Cohort n.a. n.r. n.r. n.r. ACS NSQIP Organ space SSI, leak,
ileus, reoperation, LOS,
readmission, mortality
MBP, mechanical bowel preparation; SSI, surgical-site infection; LOS, length of hospital stay; n.r., not recorded; PEG, polyethylene glycol; CDC,
Centers for Disease Control and Prevention; NNIS, National Nosocomial Infections Surveillance system; n.a., not applicable; VASQIP, Veterans Affairs
Surgical Quality Improvement Program; ACS NSQIP, American College of Surgeons National Surgical Quality Improvement Program.
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Fig. 2 Forest plot of studies that used preoperative oral antibiotics the day before colorectal surgery to prevent surgical-site infection
(SSI). A Mantel–Haenszel fixed-effect model was used for meta-analysis. Odds ratios are shown with 95 per cent confidence intervals
prophylaxis and MBP, in comparison with patients who
received only i.v. antibiotic prophylaxis and MBP (Fig. 3).
There was no heterogeneity between the studies (I2 = 0
per cent, P= 0⋅70) so a fixed-effects model was used. The
combination of preoperative oral aminoglycoside and ery-
thromycin was associated with significantly lower rates of
SSI (OR 0⋅40, 95 per cent c.i. 0⋅25 to 0⋅64; P< 0⋅001).
Seven RCTs15,19,22,23,25–27 and one cohort study28,
involving 2429 patients, examined rates of SSI in patients
who received a preoperative oral combination of an oral
aminoglycoside (kanamycin or neomycin) and metronida-
zole, along with i.v. antibiotic prophylaxis and MBP, in
comparison with patients given only i.v. antibiotic prophy-
laxis and MBP (Fig. 3). There was moderate heterogeneity
between studies (I2 = 41 per cent, P= 0⋅12) and therefore
a fixed-effects model was used. The combination of pre-
operative oral aminoglycoside and metronidazole was
associated with significantly lower rates of SSI (OR 0⋅51,
0⋅39 to 0⋅68; P< 0⋅001).
Preoperative oral antibiotics and organ space SSI
Seven RCTs17,21–23,25–27, involving 1656 patients, exam-
ined rates of organ space SSI in patients given preoperative
oral antibiotic prophylaxis, in combination with i.v. antibi-
otic prophylaxis andMBP, compared with those in patients
given only i.v. antibiotic prophylaxis with MBP. There was
minimal heterogeneity between studies (I2 = 0 per cent,
P= 1⋅00), so a fixed-effects model was used. There was
no significant association between preoperative oral
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Fig. 3 Forest plot of studies that used preoperative oral aminoglycoside and either erythromycin or metronidazole the day before
colorectal surgery to prevent surgical-site infection (SSI). A Mantel–Haenszel fixed-effect model was used for meta-analysis. Odds
ratios are shown with 95 per cent confidence intervals
antibiotics and rates of organ space SSI (OR 0⋅76, 95 per
cent c.i. 0⋅44 to 1⋅31; P= 0⋅32).
Four cohort studies2,31–33, including 38 524 patients,
compared rates of organ space SSI in patients given pre-
operative oral antibiotic prophylaxis, in combination with
i.v. antibiotic prophylaxis and MBP, with those in patients
given only i.v. antibiotic prophylaxis and MBP. There was
minimal heterogeneity between studies (I2 = 0 per cent,
P= 0⋅99) so a fixed-effects model was used. Preoperative
oral antibiotics were associated with significantly lower
rates of organ space SSI (OR 0⋅58, 0⋅52 to 0⋅66; P< 0⋅001).
Preoperative oral antibiotics and anastomotic leak
Six RCTs17,18,21,22,26,27, involving 1417 patients, examined
rates of anastomotic leak in patients undergoing colorec-
tal surgery who were given preoperative oral antibiotic
prophylaxis, in combination with i.v. antibiotic prophylaxis
and MBP, and in those who received only i.v. antibiotic
prophylaxis with MBP. There was minimal heterogeneity
between studies (I2 = 0 per cent, P= 0⋅50); therefore, a
fixed-effectsmodel was used. Therewas no significant asso-
ciation between preoperative oral antibiotics and anasto-
motic leak (OR 0⋅62, 95 per cent c.i. 0⋅30 to 1⋅28; P= 0⋅19).
Five cohort studies2,4,31–33 involving 42 329 patients,
examined rates of anastomotic leak in patients given pre-
operative oral antibiotic prophylaxis, in combination with
i.v. antibiotic prophylaxis and MBP, compared with those
in patients given only i.v. antibiotic prophylaxis with MBP.
There was minimal heterogeneity between studies (I2 = 0
per cent, P= 0⋅75), so a fixed-effects model was used. Pre-
operative oral antibiotics were associated with significantly
lower rates of anastomotic leak (OR 0⋅59, 0⋅53 to 0⋅67;
P< 0⋅001).
Preoperative oral antibiotics and paralytic ileus
Two RCTs23,27, with 779 patients, examined rates of post-
operative ileus in patients given preoperative oral antibiotic
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Fig. 4 Funnel plot of a all RCTs and b all cohort studies investigating use of oral antibiotics the day before colorectal surgery to prevent
surgical-site infection
prophylaxis, in combination with i.v. antibiotic prophylaxis
and MBP, and in those given only intravenous antibi-
otic prophylaxis with MBP. There was significant hetero-
geneity between studies (I2 = 53 per cent, P= 0⋅15), so a
random-effects model was used. There was no significant
association between preoperative oral antibiotics and rates
of paralytic ileus (OR 0⋅61, 95 per cent c.i. 0⋅11 to 3⋅38;
P= 0⋅57).
In three cohort studies2,31,33, involving 34 872 patients,
rates of postoperative ileus in patients given preoperative
oral antibiotic prophylaxis, in combination with i.v. antibi-
otic prophylaxis and MBP, were compared with those in
patients who received only intravenous antibiotic prophy-
laxis with MBP. There was minimal heterogeneity between
studies (I2 = 0 per cent, P= 0⋅63); therefore, a fixed-effects
model was used. Preoperative oral antibiotics were associ-
ated with a significantly lower rate of paralytic ileus (OR
0⋅78, 0⋅72 to 0⋅83; P< 0⋅001).
Preoperative oral antibiotics and unplanned
reoperation
Four cohort studies2,31–33, including 38 524 patients,
examined rates of unplanned reoperation in patients
undergoing colorectal surgery who received preoperative
oral antibiotic prophylaxis, in combination with intra-
venous antibiotic prophylaxis and MBP, compared with
rates among patients given only i.v. antibiotic prophylaxis
with MBP. There was no heterogeneity between studies
(I2 = 0 per cent, P= 0⋅89), so a fixed-effects model was
used. Preoperative oral antibiotics were associated with
significantly lower rates of unplanned reoperation (OR
0⋅72, 95 per cent c.i. 0⋅65 to 0⋅80; P< 0⋅001).
Preoperative oral antibiotics and length of hospital
stay following colorectal surgery
A single RCT17 with 132 patients compared postoperative
length of hospital stay in patients given preoperative oral
antibiotic prophylaxis, in combination with i.v. antibiotic
prophylaxis and MBP, with that in patients who received
only i.v. antibiotic prophylaxis withMBP.There was no sig-
nificant association between preoperative oral antibiotics
and length of stay: mean difference 0⋅3 (95 per cent c.i. –1⋅6
to 2⋅2) days (P= 0⋅76).
Three cohort studies2,4,31, involving 32 662 patients,
compared postoperative length of stay in patients given
preoperative oral antibiotic prophylaxis, in combination
with i.v. antibiotic prophylaxis and MBP, with that among
patients given only i.v. antibiotic prophylaxis with MBP.
There was significant heterogeneity between studies
(I2 = 97 per cent, P< 0⋅001); therefore, a random-effects
model was used. Preoperative oral antibiotics were asso-
ciated with a significantly shorter hospital stay: mean
difference –0⋅6 (–1⋅0 to –0⋅3) days (P = 0⋅001). In addi-
tion, one cohort study32 reported that a significantly lower
proportion of patients receiving combination oral antibi-
otics and MBP had a hospital stay of more than 30 days
compared with patients who received MBP alone.
Preoperative oral antibiotics and readmission rates
Four cohort studies2,4,31,33, involving 38 808 patients,
examined rates of unplanned readmission in patients given
preoperative oral antibiotic prophylaxis, in combination
with i.v. antibiotic prophylaxis and MBP, and among those
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who received only i.v. antibiotic prophylaxis with MBP.
There was no heterogeneity between studies (I2 = 0 per
cent, P= 0⋅78), so a fixed-effects model was used. Preop-
erative oral antibiotics were associated with significantly
lower rates of unplanned readmission (OR 0⋅87, 95 per
cent c.i. 0⋅81 to 0⋅93; P< 0⋅001).
Preoperative oral antibiotics and mortality
following colorectal surgery
Five cohort studies2,4,31–33, involving 42 341 patients, com-
pared postoperative mortality rates between patients given
preoperative oral antibiotic prophylaxis, in combination
with i.v. antibiotic prophylaxis and MBP, and those given
only i.v. antibiotic prophylaxis with MBP. There was no
heterogeneity between studies (I2 = 0 per cent, P= 0⋅78),
so a fixed-effects model was used. Preoperative oral antibi-
otics were associated with significantly lower postoperative
mortality rates (OR 0⋅65, 95 per cent c.i. 0⋅50 to 0⋅83;
P< 0⋅001).
Sensitivity analysis
A sensitivity analysis was undertaken, with only RCTs
that employed double-blinding used in the meta-
analysis14,16,18,20,22. There was minimal heterogeneity
between studies (I2 = 0 per cent, P= 0⋅44), and therefore a
fixed-effect model was used. Preoperative oral antibiotics
were significantly associated with lower rates of SSI, with
an odds ratio similar to that of the earlier analysis of all
included RCTs (OR 0⋅33, 95 per cent c.i. 0⋅18 to 0⋅59;
P< 0⋅001).
Assessment of publication bias
Visual assessment of funnel plots of the included RCTs and
cohort studies with regard to reporting of all SSIs suggested
no evidence of publication bias (Fig. 4). No data point was
generated for Hanel and colleagues15 as no events occurred
in either arm.
Discussion
The present systematic review and meta-analysis suggest
that preoperative oral antibiotic prophylaxis, in combina-
tion with mechanical bowel preparation and i.v. antibi-
otic prophylaxis, was associated with a significant reduction
in rates of SSI in elective colorectal surgery. In addition,
preoperative oral antibiotics were associated with lower
rates of organ space SSI, anastomotic leak, paralytic ileus,
unplanned reoperation, unplanned readmission and post-
operative mortality when cohort studies were considered.
These findings are in keeping with a previous
meta-analysis34 investigating the impact of preopera-
tive oral antibiotics on SSI in colorectal surgery, although
it included patients who had received preoperative oral
antibiotics for prolonged periods, patients who did not
receive i.v. antibiotic prophylaxis, and those who did not
receive MBP in combination with oral antibiotics. Koul-
louros and colleagues34 also reported only on rates of
postoperative SSI, whereas the present meta-analysis con-
sidered other outcomes of clinical significance whenever
they were available, including anastomotic leak, unplanned
reoperation and postoperative mortality.
At present, in the USA and Canada, around 40 per
cent of patients are given oral antibiotics in combination
with MBP6. The combination of oral neomycin and ery-
thromycin has been recommended for use as preoperative
antibiotic prophylaxis for colorectal surgery in an advisory
statement from the Medicare National Surgical Infection
Prevention Project35. Outside North America, this figure
is much lower. Many centres in the UK and Europe have
largely moved away from the routine use of MBP in elec-
tive colorectal surgery as ERAS and fast-track perioperative
care protocols have become the standard of care. There
are limited data on the value of using preoperative oral
antibiotics in the unprepared colon, with one cohort study4
finding no benefit, and a further two studies2,29 reporting a
reduction in SSI rates.
Based on the findings of the present meta-analysis, it
appears that, as long as one drug in the preoperative com-
bination is an aminoglycoside (kanamycin or neomycin),
then combination with either metronidazole or ery-
thromycin has equivalent efficacy in reducing SSI. There
are some pharmacological considerations that suggest
metronidazole should be the favoured agent in combi-
nation with an aminoglycoside in preoperative antibiotic
protocols. Erythromycin is a cytochrome P450 inhibitor
and the likelihood of drug interactions is greater. Further-
more, erythromycin may also prolong the QT interval and
caution is advised regarding its routine use in patients with
pre-existing cardiac disease.
The treatment effect size with regard to the reported
postoperative outcomes was generally large. It is perhaps
surprising that a single day of preoperative oral antibiotics
has such a significant and wide-ranging impact. Other
related factors may be relevant, including methodological
issues, such as variations in systems used to define and
record SSI in RCTs, diagnostic coding used to analyse large
observational studies, as well asmany clinical factors such as
case mix, complexity, operative techniques, co-morbidities
and compliance with preoperative preparation instructions.
This effect size was, however, in keeping with the review of
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Koullouros and colleagues34, which had less stringent entry
criteria. An important limitation in the present analysis was
variation in the exact type of MBP used, particularly in the
cohort studies, which often did not report the exact nature
or timing of bowel preparation. In addition, there were
variations in the definition of SSI and other complications.
Oral antibiotic prophylaxis, in combination with MBP
and i.v. antibiotics, was superior to MBP and i.v. antibiotic
prophylaxis alone in reducing SSI after elective colorectal
resections. This treatment approach was also associated
with significantly lower rates of anastomotic leak, ileus,
reoperation, length of stay, readmission and mortality.
There was no association between the combination of
antibiotics and outcome, as long as an aminoglycoside
was included. Aminoglycosides administered orally reach
very low levels in the circulation35, and toxicity is van-
ishingly rare. It is suggested that future ERAS protocols
should factor in a combination of MBP and short-course
oral antibiotic prophylaxis with an aminoglycoside and
metronidazole, and i.v. antibiotic prophylaxis at induction
of anaesthesia.
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